AAP
BLFS icon

Ardsley Advisory Partners’s BioLife Solutions BLFS Stock Holding History

Ardsley Advisory Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,500
Closed -$217K – 144
2020
Q3 		$217K Buy
+7,500
New +$162K 0.04% 124

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Ardsley Advisory Partners's BLFS Position: Q4 2020 in Review

Ardsley Advisory Partners sold out of BioLife Solutions (BLFS) in Q4 2020, closing a stake of 7,500 shares — an estimated $217K sold.

Ardsley Advisory Partners first reported a position in BLFS in Q3 2020 and held it in 1 quarter. The position peaked at $217K in Q3 2020. 128 funds tracked by Wall St. Rank hold BLFS as of Q4 2020.

  • Ardsley Advisory Partners reported no remaining BioLife Solutions position as of Q4 2020 after selling out during the quarter.
  • Ardsley Advisory Partners sold 7,500 BioLife Solutions shares in Q4 2020, an estimated $217K.
  • Ardsley Advisory Partners first reported a position in BioLife Solutions in Q3 2020 and held it in 1 quarter.
  • Ardsley Advisory Partners's BioLife Solutions position peaked at $217K in Q3 2020.
  • 128 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2020.

Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.